Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $66.31 Average Price Target from Analysts
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been assigned a consensus recommendation of “Buy” from the thirteen analysts that are covering the company, MarketBeat Ratings reports. Twelve research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been assigned a consensus recommendation of “Buy” from the thirteen analysts that are covering the company, MarketBeat Ratings reports. Twelve research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price […]
